Sandu Pharmaceuticals Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 5 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Net profit of Sandu Pharmaceuticals declined 87.88% to Rs 0.04 crore in the quarter ended March 2026 as against Rs 0.33 crore during the previous quarter ended March 2025. Sales rose 19.76% to Rs 16.85 crore in the quarter ended March 2026 as against Rs 14.07 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.19% to Rs 1.77 crore in the year ended March 2026 as against Rs 1.55 crore during the previous year ended March 2025. Sales rose 4.08% to Rs 69.93 crore in the year ended March 2026 as against Rs 67.19 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 May 2026.

Net profit of Sandu Pharmaceuticals rose 75.00% to Rs 0.98 crore in the quarter ended December 2025 as against Rs 0.56 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 18.76 crore in the quarter ended December 2025 as against Rs 18.37 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News